Cargando…

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment

The knowledge of chronic lymphocytic leukemia (CLL) has progressively deepened during the last forty years. Research activities and clinical studies have been remarkably fruitful in novel findings elucidating multiple aspects of the pathogenesis of the disease, improving CLL diagnosis, prognosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Carretero, Claudia, González-Gascón-y-Marín, Isabel, Rodríguez-Vicente, Ana E., Quijada-Álamo, Miguel, Hernández-Rivas, José-Ángel, Hernández-Sánchez, María, Hernández-Rivas, Jesús María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151186/ https://www.ncbi.nlm.nih.gov/pubmed/34068813 http://dx.doi.org/10.3390/diagnostics11050853

Ejemplares similares

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2021)

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2023)

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
por: Quijada-Álamo, Miguel, et al.
Publicado: (2021)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
por: Quijada‐Álamo, Miguel, et al.
Publicado: (2021)

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
por: Muñoz-Novas, Carolina, et al.
Publicado: (2018)

Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
por: Rodríguez-Vicente, Ana E., et al.
Publicado: (2017)

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
por: Moreno, Carol, et al.
Publicado: (2021)

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
por: Quijada-Álamo, Miguel, et al.
Publicado: (2017)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012)

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia
por: Hernández, José Ángel, et al.
Publicado: (2015)

Mutation Status and Immunoglobulin Gene Rearrangements in Patients from Northwest and Central Region of Spain with Chronic Lymphocytic Leukemia
por: González-Gascón y Marín, I., et al.
Publicado: (2014)

Targeted genome editing in acute lymphoblastic leukemia: a review
por: Montaño, Adrián, et al.
Publicado: (2018)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
por: Quijada-Álamo, Miguel, et al.
Publicado: (2020)

The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies
por: Hernández-Rivas, José-Ángel, et al.
Publicado: (2022)

New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update
por: Montaño, Adrián, et al.
Publicado: (2018)

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021)

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
por: Loscertales, Javier, et al.
Publicado: (2023)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
por: Hernández-Sánchez, María, et al.
Publicado: (2018)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

PB2293: REAL WORLD STUDY OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE ELDERLY: FOURTEEN YEARS OF ONE CENTER’S EXPERIENCE
por: De Ascanio, Victoria Ramos, et al.
Publicado: (2023)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2022)

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2023)

The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia
por: Gordon, Max J., et al.
Publicado: (2021)

A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival
por: Ijurko, Carla, et al.
Publicado: (2022)

Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012)

The genomic landscape of chronic lymphocytic leukemia: clinical implications
por: Quesada, Víctor, et al.
Publicado: (2013)

Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
por: Teramo, Antonella, et al.
Publicado: (2020)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
por: Puiggros, Anna, et al.
Publicado: (2017)

The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials
por: Fisher, A., et al.
Publicado: (2023)

Identification of expression patterns in the progression of disease stages by integration of transcriptomic data
por: Aibar, Sara, et al.
Publicado: (2016)

P463: DATABASE GUIDED STRATEGY FOR THE CHARACTERIZATION OF LEUKEMIC STEM CELL IN ACUTE MYELOBLASTIC LEUKEMIA. IMPLICATIONS IN THE DIAGNOSIS AND PROGNOSIS OF THE DISEASE.
por: Piñero, Paula, et al.
Publicado: (2023)

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence
por: Feagan, Brian G., et al.
Publicado: (2020)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia
por: Kasar, S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_obgg8j77dh2t86rcg5tshpsf3r